Recombinant UPF0678 fatty acid-binding protein-like protein SAV_1365 (SAV_1365)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Specify your required tag type for preferential development.
Synonyms
SAV_1365UPF0678 fatty acid-binding protein-like protein SAV_1365
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-180
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptomyces avermitilis (strain ATCC 31267 / DSM 46492 / JCM 5070 / NBRC 14893 / NCIMB 12804 / NRRL 8165 / MA-4680)
Target Names
SAV_1365
Target Protein Sequence
MVDPAPEHPY PDGHRPDEAP APHALLEPVL GLLGSWYGRG EGGYPTLTGD FGYAQELTFS HDGRPFLRYE ARAWLLDADD APLRPSAREC GWWRLQPDGR VEALITQPTG IAEIMVGRAT GNTIDLSTHE VALAPTAKKV NATRRRYTLT DDDTLTFHHD LEAVGQPMQH HLSARLRRRG
Uniprot No.

Target Background

Function
This heme-binding protein scavenges peroxynitrite and protects free L-tyrosine from peroxynitrite-mediated nitration by acting as a peroxynitrite isomerase, converting peroxynitrite to nitrate. This suggests a role in peroxynitrite sensing and detoxification of reactive nitrogen and oxygen species (RNS and ROS). While capable of in vitro nitric oxide (NO) binding, its primary in vivo function may be as a peroxynitrite level sensor.
Database Links
Protein Families
UPF0678 family

Q&A

What expression systems are optimal for recombinant UPF0678 fatty acid-binding protein-like protein SAV_1365?

Recombinant UPF0678 fatty acid-binding protein-like protein SAV_1365 can be successfully expressed in multiple host systems, each offering distinct advantages. E. coli and yeast expression systems typically provide the highest yields and shortest turnaround times, making them suitable for initial characterization studies or when large quantities are required. For applications requiring proper post-translational modifications or maintenance of specific protein activities, insect cells with baculovirus or mammalian cell expression systems are recommended despite their lower yields . When selecting an expression system, researchers should consider the downstream applications and whether native folding and post-translational modifications are critical for the intended experiments.

How can I optimize protein yield while maintaining proper folding of SAV_1365?

Optimizing SAV_1365 expression requires balancing yield with proper protein folding. For E. coli-based expression, consider these methodological approaches:

  • Temperature modulation: Lower induction temperatures (16-25°C) often improve proper folding

  • Induction optimization: Test various IPTG concentrations (0.1-1.0 mM) and induction times

  • Co-expression with chaperones: Molecular chaperones like GroEL/GroES can facilitate proper folding

  • Fusion tags selection: Solubility-enhancing tags (MBP, SUMO, or TrxA) may improve folding

For eukaryotic expression systems, consider optimizing transfection conditions, harvest timing, and media supplementation with lipids that might facilitate proper folding of this fatty acid-binding protein. Similar techniques have been successfully applied to other recombinant proteins, as demonstrated in surface display methodologies .

What purification strategy provides the highest purity and activity for SAV_1365?

A multi-step purification strategy is recommended for SAV_1365:

  • Initial capture: Affinity chromatography using an appropriate tag (His, GST, etc.)

  • Intermediate purification: Ion exchange chromatography based on the protein's theoretical pI

  • Polishing: Size exclusion chromatography to remove aggregates and achieve high purity

For fatty acid-binding proteins like SAV_1365, it's critical to monitor ligand binding capacity throughout purification, as binding activity can be compromised during purification steps. Consider implementing activity assays between purification steps to ensure the final product retains its fatty acid binding functionality. Purification under reducing conditions may be necessary to maintain the correct structural conformation, similar to approaches used for other functional proteins .

What methods are most effective for confirming the proper folding and activity of purified SAV_1365?

To confirm proper folding and activity of purified SAV_1365, employ a combination of structural and functional analyses:

Structural Analysis:

  • Circular dichroism (CD) spectroscopy to assess secondary structure content

  • Thermal shift assays to determine protein stability

  • Dynamic light scattering (DLS) to evaluate homogeneity and detect aggregation

  • Limited proteolysis to verify compact folding

Functional Analysis:

  • Fatty acid binding assays using fluorescent probes (ANS, DAUDA)

  • Isothermal titration calorimetry (ITC) to determine binding constants

  • Fluorescence displacement assays to measure ligand specificity

These approaches should be used complementarily as structural integrity doesn't always guarantee functional activity. For fatty acid-binding proteins, binding assays are particularly important to confirm that the recombinant protein maintains its native functionality after purification, similar to methodologies used to analyze other fatty acid binding proteins .

How can I determine the specific fatty acid binding profile of SAV_1365?

To determine the fatty acid binding profile of SAV_1365, implement a systematic approach:

  • Competitive binding assays: Using a fluorescently labeled fatty acid as a reporter ligand, measure displacement by various unlabeled fatty acids to determine relative binding affinities.

  • Direct binding measurements:

    MethodData ObtainedAdvantages
    Isothermal Titration CalorimetryBinding constants, stoichiometry, enthalpyLabel-free, direct measurement
    Surface Plasmon ResonanceAssociation/dissociation kineticsReal-time measurement
    Microscale ThermophoresisBinding constants in solutionLow sample consumption
  • Structural studies: X-ray crystallography or NMR spectroscopy with bound fatty acids can provide atomic-level details of binding interactions.

  • Mutagenesis studies: Creating point mutations at predicted binding site residues can confirm the binding pocket and mechanism.

This comprehensive approach has been effective in characterizing other fatty acid binding proteins, revealing their specificity for different lipid molecules, binding mechanisms, and potential biological functions .

How can SAV_1365 be utilized in protein-surface display systems?

SAV_1365 can be adapted for surface display systems using methodologies similar to those established for other proteins. The sortase-mediated approach represents a particularly effective strategy:

  • Generate a fusion construct containing SAV_1365 with a cell wall sorting motif (CWM) and co-express with an appropriate sortase enzyme (like YhcS in B. subtilis)

  • The sortase will catalyze the covalent attachment of SAV_1365 to the peptidoglycan cell wall, resulting in stable surface display

  • Validate surface expression using:

    • Flow cytometry with fluorescently labeled antibodies against SAV_1365 or an epitope tag

    • Western blot analysis comparing protoplast fractions to confirm proper localization

    • Functional assays to verify that the displayed protein retains activity

This approach has proven successful for displaying other functional proteins on bacterial surfaces, as demonstrated in studies with protein A display on B. subtilis, where approximately 28% of cells showed significant surface expression compared to control strains .

What methodological approaches would enable the study of SAV_1365's potential antioxidant properties?

To investigate potential antioxidant properties of SAV_1365, drawing from methodologies used with other fatty acid binding proteins:

  • Free radical scavenging assays:

    • DPPH (2,2-diphenyl-1-picrylhydrazyl) assay

    • ABTS (2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid) assay

    • DCF (2′,7′-dichlorofluorescein) fluorescence assay to measure protection against H₂O₂-induced oxidative stress

  • Lipid peroxidation inhibition:

    • Test protection against both hydrophilic (AAPH) and lipophilic (AMVN) free radical generators

    • Measure malondialdehyde (MDA) production as a marker of lipid peroxidation

  • Identification of antioxidant mechanisms:

    • Mass spectrometry analysis to identify oxidative modifications to the protein

    • Site-directed mutagenesis of potential antioxidant residues (particularly methionines)

    • Analysis of fatty acid binding effects on antioxidant capacity

This systematic approach would determine whether SAV_1365 possesses antioxidant properties similar to those observed in other fatty acid binding proteins, such as L-FABP, which demonstrated significant protection against oxidative stress with increasing protein concentration .

How should I design experiments to distinguish between direct antioxidant effects of SAV_1365 and its fatty acid-sequestering properties?

Designing experiments to differentiate between direct antioxidant activity and fatty acid-sequestering effects requires a carefully controlled approach:

  • Comparative assays with different free radical generators:

    • Compare antioxidant efficiency against hydrophilic (AAPH) versus lipophilic (AMVN) free radical generators

    • If SAV_1365 functions primarily through fatty acid sequestration, it should show greater effectiveness against lipophilic radical generators

    • If it has direct antioxidant activity, it may protect against both types of radicals

  • Mutational analysis:

    • Generate SAV_1365 mutants with impaired fatty acid binding but intact protein structure

    • Compare antioxidant capacity of wild-type versus binding-deficient mutants

    • Reduced activity in binding-deficient mutants would suggest fatty acid sequestration as the primary mechanism

  • Pre-loading experiments:

    • Pre-saturate SAV_1365 with non-oxidizable fatty acids

    • Test whether pre-loaded protein retains antioxidant activity

    • Diminished activity would support a sequestration mechanism

These methodological approaches, similar to those used with L-FABP, which demonstrated differential protection against hydrophilic versus lipophilic radical generators, can help elucidate SAV_1365's antioxidant mechanism .

What are the appropriate statistical approaches for analyzing SAV_1365 binding data from multiple experimental replicates?

When analyzing SAV_1365 binding data across multiple experiments, implement these statistical approaches:

Optimum experimental design using statistical software like SAS can be employed to maximize the information obtained while minimizing the number of experiments required .

How can molecular dynamics simulations enhance our understanding of SAV_1365's fatty acid binding mechanism?

Molecular dynamics (MD) simulations provide valuable insights into SAV_1365's fatty acid binding mechanisms:

  • System preparation:

    • Generate homology models if crystal structures are unavailable

    • Parameterize fatty acid ligands using quantum mechanical calculations

    • Set up protein-ligand complexes in explicit solvent systems

  • Simulation protocols:

    • Equilibration followed by production runs of 100-500 ns

    • Multiple replicas with different starting conditions

    • Enhanced sampling techniques (metadynamics, umbrella sampling) for energy barriers

  • Analysis of binding dynamics:

    • Calculate binding free energies via MM/PBSA or thermodynamic integration

    • Identify key residues through interaction energy decomposition

    • Characterize conformational changes upon ligand binding

    • Map ligand entry/exit pathways through steered MD

  • Validation approaches:

    • Compare computational predictions with experimental mutagenesis data

    • Use simulation insights to design mutations that alter binding specificity

    • Predict effects of different fatty acids on protein stability and dynamics

These simulation approaches can reveal atomic-level details of binding mechanisms that are difficult to observe experimentally, similar to methods applied to other fatty acid binding proteins to understand their specificity and function .

What are the methodological considerations for investigating the role of post-translational modifications in SAV_1365 function?

Investigating post-translational modifications (PTMs) of SAV_1365 requires a comprehensive strategy:

  • PTM identification:

    • High-resolution mass spectrometry (MS/MS) analysis of protein expressed in different systems

    • Enrichment techniques for specific modifications (phosphopeptides, glycopeptides)

    • Comparison of modification patterns between expression systems (bacterial vs. mammalian)

  • Functional impact assessment:

    PTM TypeAnalytical MethodFunctional Implication
    PhosphorylationPhosphomimetic mutations (S/T→D/E)May regulate binding affinity
    AcetylationMS/MS before/after deacetylase treatmentCould affect protein stability
    GlycosylationExpression in glycosylation-deficient cellsMay impact solubility and half-life
  • Site-directed mutagenesis:

    • Generate mutants that cannot be modified at specific sites

    • Compare binding properties and stability to wild-type protein

    • Use cell-based assays to assess functional differences in biological contexts

  • Structure-function relationships:

    • Determine if PTMs occur near the fatty acid binding pocket

    • Assess whether modifications alter protein conformational dynamics

    • Investigate if PTMs affect interactions with cellular partners

This systematic approach can reveal whether post-translational modifications are critical for SAV_1365 function, potentially explaining differences observed when the protein is expressed in different host systems .

What methodological approaches would enable the utilization of SAV_1365 in drug delivery systems?

Developing SAV_1365 as a drug delivery vehicle requires several methodological considerations:

  • Drug binding characterization:

    • Screen potential drug candidates for binding to SAV_1365 using fluorescence displacement assays

    • Determine binding constants and stoichiometry through ITC or fluorescence titration

    • Characterize binding site interactions through crystallography or NMR with bound drugs

  • Protein engineering strategies:

    • Site-directed mutagenesis to enhance binding of specific drug molecules

    • Creation of fusion proteins to incorporate targeting moieties

    • Surface modification to improve circulation time and reduce immunogenicity

  • Formulation development:

    • Optimize protein-drug complex stability under physiological conditions

    • Develop lyophilization protocols that preserve activity

    • Characterize release kinetics under various pH and temperature conditions

  • Surface display applications:

    • Adapt sortase-mediated display methods to create cell-based drug delivery systems

    • Evaluate display efficiency through flow cytometry and functional assays

    • Assess binding capacity and reusability similar to approaches used with protein A display systems

These approaches could leverage the fatty acid binding properties of SAV_1365 to create novel drug delivery systems, taking advantage of methodologies established for other surface-displayed proteins .

How can I design experiments to elucidate the physiological role of SAV_1365 in its native context?

To investigate the physiological role of SAV_1365 in its native context:

  • Gene expression analysis:

    • Determine expression patterns under various growth conditions

    • Identify co-regulated genes through transcriptomic analysis

    • Map expression to specific physiological states or stress responses

  • Gene knockout/knockdown studies:

    • Generate gene deletion mutants using CRISPR-Cas9 or homologous recombination

    • Perform phenotypic characterization under various conditions

    • Conduct complementation studies with wild-type and mutant versions

  • Protein-protein interaction studies:

    • Perform pull-down assays coupled with mass spectrometry

    • Validate interactions using techniques like bioluminescence resonance energy transfer (BRET)

    • Map interaction interfaces through cross-linking mass spectrometry

  • Metabolomic analysis:

    • Compare lipid profiles between wild-type and knockout strains

    • Assess changes in fatty acid metabolism under different conditions

    • Identify specific fatty acids that may be physiological ligands

  • Stress response experiments:

    • Test sensitivity to oxidative stress, similar to experiments with L-FABP

    • Examine membrane integrity and composition in knockout vs. wild-type

    • Investigate potential roles in antioxidant defense mechanisms

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.